Anales de pediatria最新文献

{"title":"2025: un paso más para seguir avanzando","authors":"Luis Carlos Blesa Baviera , Susana Blesa Chiralt","doi":"10.1016/j.anpedi.2025.503892","DOIUrl":"10.1016/j.anpedi.2025.503892","url":null,"abstract":"","PeriodicalId":7783,"journal":{"name":"Anales de pediatria","volume":"102 6","pages":"Article 503892"},"PeriodicalIF":1.5,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144185257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploración del papel de los índices celulares de eosinófilos en el diagnóstico de la esofagitis eosinofílica","authors":"Julio César Moreno-Alfonso , Sharom Barbosa-Velásquez , Ada Molina Caballero , Alberto Pérez Martínez , María Concepción Yárnoz Irazábal","doi":"10.1016/j.anpedi.2025.503809","DOIUrl":"10.1016/j.anpedi.2025.503809","url":null,"abstract":"","PeriodicalId":7783,"journal":{"name":"Anales de pediatria","volume":"102 6","pages":"Article 503809"},"PeriodicalIF":1.5,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144185263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Valoración de la seguridad de los pacientes durante el transporte interhospitalario","authors":"Patricia Corniero ,&nbsp;Mònica Girona-Alarcón ,&nbsp;Carme Alejandre ,&nbsp;Roi Campos ,&nbsp;Nuria Millán García del Real ,&nbsp;Elisabeth Esteban","doi":"10.1016/j.anpedi.2025.503884","DOIUrl":"10.1016/j.anpedi.2025.503884","url":null,"abstract":"<div><h3>Objective</h3><div>The transport of critically ill pediatric patients is associated with the occurrence of adverse events (AE) and incidents that worsen patient outcomes. The primary objective was to determine the AEs and incidents that occurred during interhospital transport and to analyze changes after the implementation of safety measures. The secondary objective was to analyze the association between the presence of family accompanying the patient in the ambulance and the number of incidents.</div></div><div><h3>Material and methods</h3><div>Prospective and observational study, including patients transferred by a specialized pediatric transport team during two periods: period<!--> <!-->1 (2017-2018) and period<!--> <!-->2 (2022-2023). We compared incidents in the two periods after the implementation of safety measures. We also compared the presence of parents during the transport and its association with the occurrence of incidents.</div></div><div><h3>Results</h3><div>We analyzed 1369 transports. A total of 273 (20.7%) patients experienced some incident during transport, with a lower percentage in period 2 (29.2% vs 12.0%; <em>P</em> <!-->&lt;<!--> <!-->.001), especially in patients with clinical incidents (20.3% vs 5.1%; <em>P</em> <!-->&lt;<!--> <!-->.001). Incidents involving a lack of devices or supplies were least frequent, with no differences between the two periods.</div><div>Family accompanied the patient in the ambulance more frequently in the second period (76.0% vs 82.6%; <em>P</em> <!-->=<!--> <!-->.001), a finding that was not associated with an increase in incidents, with a higher percentage of transports with parents in the care cabin.</div></div><div><h3>Conclusions</h3><div>Interhospital pediatric transport performed by teams trained in clinical safety leads to few incidents. Implementing measures to improve patient safety can reduce the frequency of these incidents and optimize care quality.</div></div>","PeriodicalId":7783,"journal":{"name":"Anales de pediatria","volume":"102 6","pages":"Article 503884"},"PeriodicalIF":1.5,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144185336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efectos de los medios digitales en la salud física y el desarrollo","authors":"María Angustias Salmerón-Ruiz ,&nbsp;Cristina García de Ribera ,&nbsp;Valero Sebastián Barberán ,&nbsp;Lefa Eddy Ives ,&nbsp;Julio Álvarez-Pitti","doi":"10.1016/j.anpedi.2025.503876","DOIUrl":"10.1016/j.anpedi.2025.503876","url":null,"abstract":"<div><div>The goal of screen health is to reduce the deleterious impact of the use of screens, digital content and connected devices (collectively known as the “Internet of Things”) and harmful design. That is, of any information, application, software or hardware that affects physical, mental, social, sexual or brain health. With this objective in mind, the screen health working group of the Health Promotion Committee of the Asociación Española de Pediatría (AEP, Spanish Association of Pediatrics) published the Family Digital Plan (FDP) online in 2022 based on the evidence available through 2021. The purpose of this article is to offer a review of the evidence published from 2021 and to determine whether changes need to be made to the recommendations of the FDP. It is reasonable to state that there is sufficient evidence supporting the association between screen time and the displacement of healthy lifestyle habits such as sleep, diet, physical activity and face-to-face social interactions. Furthermore, screen use also has an impact on cardiovascular risk, visual health, brain volume and quality of life. Its effects are greater in children, especially those aged less than six years, and in adolescents, as it interferes with neurodevelopment and affect integration and reduces the ability to regulate emotion. The Health Promotion Committee of the AEP considers several actions necessary: the revision of the recommendations of the FDP, declaring screen use a public health problem, improving the training of pediatricians to prevent and detect it, improving research on the use of screens in education and health care systems, the establishment of legislation by governments to protect health and development, and advocating for the requirement of rigorous research to demonstrate, from the early stages of design and development, that technological products or services are safe for the health and brain of the population.</div></div>","PeriodicalId":7783,"journal":{"name":"Anales de pediatria","volume":"102 6","pages":"Article 503876"},"PeriodicalIF":1.5,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144185259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Informe anual 2025 de los editores de Anales de Pediatría","authors":"Montserrat Antón-Gamero ,&nbsp;Alejandro Avila-Alvarez ,&nbsp;Josep Vicent Balaguer-Martínez ,&nbsp;Mercedes Bueno Campaña ,&nbsp;Rafael Galera-Martínez","doi":"10.1016/j.anpedi.2025.503900","DOIUrl":"10.1016/j.anpedi.2025.503900","url":null,"abstract":"","PeriodicalId":7783,"journal":{"name":"Anales de pediatria","volume":"102 6","pages":"Article 503900"},"PeriodicalIF":1.5,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144185274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Recomendaciones de manejo de la dispepsia funcional del Grupo de Trabajo de Motilidad y Trastornos Gastrointestinales Funcionales de la SEGHNP","authors":"Miguel Ángel Carro Rodríguez ,&nbsp;Inmaculada Hidalgo Montes ,&nbsp;Carmen Jovani Casano ,&nbsp;Aránzazu Recio Linares ,&nbsp;Etna Masip Simó ,&nbsp;Gloria Rodrigo Garcia ,&nbsp;Andrés Bodas Pinedo ,&nbsp;en representación del Grupo de Trabajo de Motilidad y Trastornos Gastrointestinales funcionales de la SEGHNP","doi":"10.1016/j.anpedi.2025.503860","DOIUrl":"10.1016/j.anpedi.2025.503860","url":null,"abstract":"<div><h3>Introduction</h3><div>Functional dyspepsia (FD) is a functional gastrointestinal disorder that affects a significant number of patients, especially adolescents. Diagnosis is often challenging on account of both the differential diagnosis with organic diseases and the overlap with other disorders involving the gut-brain axis. Furthermore, there is a lack of scientific evidence on the effectiveness of the different treatments. As a result, there is evidence of substantial heterogeneity in the management of these patients due, in part, to the absence of clinical practice guidelines on this disease.</div></div><div><h3>Material and methods</h3><div>A group was formed that consisted of 19 members of the working group on motility and functional gastrointestinal disorders (FGIDS) of the SEGHNP. The group defined 27 clinical questions regarding the management of FD. After a review of the literature and two rounds of anonymous voting, the group elaborated a document summarizing the current evidence and offering recommendations.</div></div><div><h3>Results</h3><div>The group produced a summary of the evidence and developed 27 recommendations on FD.</div></div><div><h3>Conclusion</h3><div>We developed an algorithm with the aim of standardizing the management of patients with FD.</div></div>","PeriodicalId":7783,"journal":{"name":"Anales de pediatria","volume":"102 5","pages":"Article 503860"},"PeriodicalIF":1.5,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143907768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Síndrome de resistencia a las hormonas tiroideas: detección prenatal y manejo posnatal en un recién nacido","authors":"Beatriz Parreira de Andrade ,&nbsp;Marta Barbosa ,&nbsp;Patrícia Tavares ,&nbsp;Maria Adriana Rangel ,&nbsp;Rosa Arménia Campos","doi":"10.1016/j.anpedi.2025.503772","DOIUrl":"10.1016/j.anpedi.2025.503772","url":null,"abstract":"","PeriodicalId":7783,"journal":{"name":"Anales de pediatria","volume":"102 5","pages":"Article 503772"},"PeriodicalIF":1.5,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143907769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dolor por procedimientos en pediatría: óxido nitroso y efecto invernadero","authors":"Itziar Marsinyach Ros ,&nbsp;Marta Pérez Alba ,&nbsp;en representación del Comité de Dolor Infantil de la Asociación Española de Pediatría (AEP)","doi":"10.1016/j.anpedi.2025.503839","DOIUrl":"10.1016/j.anpedi.2025.503839","url":null,"abstract":"","PeriodicalId":7783,"journal":{"name":"Anales de pediatria","volume":"102 5","pages":"Article 503839"},"PeriodicalIF":1.5,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143907915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evolución de los pacientes con cribado de cardiopatías congénitas críticas alterado en función del momento de realización","authors":"Elena Granda ,&nbsp;Silvia Pérez-Porra ,&nbsp;Silvia Martín-Ramos ,&nbsp;Sara Marín-Urueña ,&nbsp;Sonia Caserío-Carbonero","doi":"10.1016/j.anpedi.2025.503799","DOIUrl":"10.1016/j.anpedi.2025.503799","url":null,"abstract":"","PeriodicalId":7783,"journal":{"name":"Anales de pediatria","volume":"102 5","pages":"Article 503799"},"PeriodicalIF":1.5,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143907770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mejoría de la inflamación intestinal tras tratamiento con moduladores de la proteína CFTR en pacientes con fibrosis quística","authors":"Ruth García Romero ,&nbsp;Concepción López Cárdenes ,&nbsp;Elena Crehuá Gaudiza ,&nbsp;Marina Álvarez Beltrán ,&nbsp;Mercedes Murray Hurtado ,&nbsp;Carlos Tutau Gómez ,&nbsp;Inés Loverdos Eseverri ,&nbsp;Encarni Torcuato Rubio ,&nbsp;Camila García Volpe ,&nbsp;Enrique Salcedo Lobato ,&nbsp;María Medina Martínez ,&nbsp;Carmen Martin Fernández ,&nbsp;Ana Moreno Álvarez ,&nbsp;Ana Reyes Domínguez ,&nbsp;David González Jiménez ,&nbsp;Grupo de trabajo de Fibrosis Quística y Páncreas de la SEGHNP","doi":"10.1016/j.anpedi.2025.503836","DOIUrl":"10.1016/j.anpedi.2025.503836","url":null,"abstract":"<div><h3>Introduction</h3><div>Treatments with CFTR protein modulators have improved respiratory and digestive health in patients with cystic fibrosis.</div></div><div><h3>Objective</h3><div>To assess changes in intestinal inflammation through the analysis of fecal calprotectin in patients with cystic fibrosis during treatment with CFTR modulators.</div></div><div><h3>Material and methods</h3><div>Prospective multicenter study of changes in fecal calprotectin in patients with cystic fibrosis treated with CFTR modulators, comparing double combinations (lumacaftor/ivacaftor or tezacaftor/ivacaftor) and triple combinations (elexacaftor/tezacaftor/ivacaftor). We collected data before treatment initiation and at 6<!--> <!-->and 12<!--> <!-->months.</div></div><div><h3>Results</h3><div>Analysis of 117 patients (69% with F508del/F508del). The median baseline fecal calprotectin level was 49<!--> <!-->μg/g (IQR: 23-108); 48.7% had median levels greater than 50<!--> <!-->μg/g and 11% levels greater than 250<!--> <!-->μg/g. Fecal calprotectin decreased in both groups, with a greater decrease in patients treated with elexacaftor/tezacaftor/ivacaftor. We found a progressive decrease in abnormal values (&gt;<!--> <!-->50<!--> <!-->μg/g) at 6<!--> <!-->months (48.7% vs 33.1%; <em>P</em> <!-->=<!--> <!-->.0067) and at 12<!--> <!-->months (54% vs 33.5%; <em>P</em> <!-->=<!--> <!-->.0218). In the elexacaftor/tezacaftor/ivacaftor group, only two patients at 6<!--> <!-->months and one patient at 12<!--> <!-->months had levels greater than 250<!--> <!-->μg/g. The estimated change at 12<!--> <!-->months in the triple therapy group compared to the other group was −133<!--> <!-->μg/g (95%<!--> <!-->CI: −<!--> <!-->254 to −<!--> <!-->13; <em>P</em> <!-->=<!--> <!-->.030); and, adjusting for sex, probiotics and <em>Pseudomonas aeruginosa</em>, −<!--> <!-->130<!--> <!-->μg/g (−259 to −<!--> <!-->1; <em>P</em> <!-->=<!--> <!-->.049).</div></div><div><h3>Conclusions</h3><div>Treatment with CFTR modulators reduces intestinal inflammation in patients with cystic fibrosis, with a greater decrease in patients treated with triple therapy.</div></div>","PeriodicalId":7783,"journal":{"name":"Anales de pediatria","volume":"102 5","pages":"Article 503836"},"PeriodicalIF":1.5,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143907917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}